InvestorsHub Logo
Followers 74
Posts 9168
Boards Moderated 0
Alias Born 04/25/2002

Re: pegs1 post# 43896

Wednesday, 03/09/2022 11:00:36 PM

Wednesday, March 09, 2022 11:00:36 PM

Post# of 44690
pegs1
JJ probably felt that the current EUA application has some weaknesses, and rather than WAIT for potential rejection....include the BTD to improve the odds of success. That's my guess.

I feel that the bigger story for RLFTF (over the short-term), and one that has higher odds for success, is the June 5, 2022 PDUFA event. With full FDA approval for ACER-001 (to treat Urea Cycle Disorders), that paves the way for new revenues for RLFTF. We could see a pps boost if all goes well with that initiative.

https://www.acertx.com/2021/10/06/acer-therapeutics-and-relief-therapeutics-announce-fda-acceptance-for-filing-of-new-drug-application-for-acer-001-to-treat-urea-cycle-disorders/